Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
The "Plant Breeding and CRISPR Plants - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Plant Breeding and CRISPR Plants was valued at ...
Both stocks are risky, but one is far less so. This juicy upside potential comes at a cost. Investors seeking stocks with ...
Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...
BACKGROUND:It Takes 2tm is a critical health initiative highlighting the importance of complete testing and early diagnosis of chronic kidney disease (CKD), particularly among those who have type 2 ...
Morning Overview on MSN
Programmable CRISPR cuts stem cell timing from months to weeks
Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...
Dyadic International Inc (NASDAQ:DYAI) has successfully transitioned from a platform-centric R&D organization to a commercially focused biotechnology company. The company achieved its first commercial ...
ZME Science on MSN
Scientists Engineered a Supercharged Quorn Fungus That Makes Nearly Double the Protein
Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback